CDKN2B
関連文献

“Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins”. Oncogene 11 (8):  1581–8. (October 1995). PMID 7478582.
“Genomic structure, expression and mutational analysis of the P15 (MTS2) gene”. Oncogene 11 (5):  987–91. (September 1995). PMID 7675459.
“Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer”. Cancer Research 55 (7):  1448–51. (April 1995). PMID 7882351.
“Deletion of p16 and p15 genes in brain tumors”. Cancer Research 54 (24):  6353–8. (December 1994). PMID 7987828.
“Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function”. Genes & Development 8 (24):  2939–52. (December 1994). doi:10.1101/gad.8.24.2939. PMID 8001816.
“A cell cycle regulator potentially involved in genesis of many tumor types”. Science 264 (5157):  436–40. (April 1994). doi:10.1126/science.8153634. PMID 8153634. https://zenodo.org/record/1231245.
“The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2”. Genes & Development 11 (4):  492–503. (February 1997). doi:10.1101/gad.11.4.492. PMID 9042862.
“Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells”. Molecular and Cellular Biology 17 (5):  2458–67. (May 1997). doi:10.1128/MCB.17.5.2458. PMC 232094. PMID 9111314. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC232094/.
“Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15”. Nature 387 (6631):  417–22. (May 1997). doi:10.1038/387417a0. PMID 9163429.
“Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor”. Cancer Research 57 (14):  2966–73. (July 1997). PMID 9230210.
“Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines”. The Journal of Biological Chemistry 274 (49):  35053–8. (December 1999). doi:10.1074/jbc.274.49.35053. PMID 10574984.
“Tumor suppressor INK4: refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR data”. Protein Science 9 (6):  1120–8. (June 2000). doi:10.1110/ps.9.6.1120. PMC 2144649. PMID 10892805. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2144649/.
“DNA cloning using in vitro site-specific recombination”. Genome Research 10 (11):  1788–95. (November 2000). doi:10.1101/gr.143000. PMC 310948. PMID 11076863. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC310948/.
“Repression of p15INK4b expression by Myc through association with Miz-1”. Nature Cell Biology 3 (4):  392–9. (April 2001). doi:10.1038/35070076. PMID 11283613.
“Evaluation of alterations in the tumor suppressor genes INK4A and INK4B in human bladder tumors”. Gene Probes. Methods Mol. Biol.. 179. (2002). pp. 43–59. doi:10.1385/1-59259-238-4:043. ISBN 1-59259-238-4. PMID 11692873
“Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell lines”. In Vivo 15 (5):  443–6. (2002). PMID 11695244.
“Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression”. Journal of Neuro-Oncology 55 (3):  149–58. (December 2001). doi:10.1023/A:1013863630293. PMID 11859969.
“Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome”. The Journal of Investigative Dermatology 118 (3):  493–9. (March 2002). doi:10.1046/j.0022-202x.2001.01682.x. PMID 11874489.
“Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer”. International Journal of Cancer 99 (4):  579–82. (June 2002). doi:10.1002/ijc.10331. PMID 11992549.
“Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway”. Canadian Journal of Cardiology 37 (4):  655-664. (2021). doi:10.1016/j.cjca.2020.05.016. PMID 32428618.